Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1

Intercellular adhesion molecule-1 (ICAM-1) is the cell surface receptor for the major class of human rhinoviruses, and tICAM453, a truncated, soluble form of ICAM-1, has been shown previously to be a potent in vitro inhibitor of rhinovirus. In this report, we have investigated the in vivo efficacy o...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 1997-04, Vol.155 (4), p.1206-1210
Main Authors: HUGUENEL, E. D, COHN, D, OHLIN, A. C, SCUDERI, P, DOCKUM, D. P, GREVE, J. M, FOURNEL, M. A, HAMMOND, L, IRWIN, R, MAHONEY, J, MCCLELLAND, A, MUCHMORE, E
Format: Article
Language:English
Subjects:
Administration, Intranasal
Animals
Antibodies, Viral - analysis
Biological and medical sciences
Common Cold - immunology
Common Cold - prevention & control
Intercellular Adhesion Molecule-1 - administration & dosage
Intercellular Adhesion Molecule-1 - therapeutic use
Macaca mulatta
Medical sciences
Pan troglodytes
Pharmacology. Drug treatments
Respiratory system
rhinovirus
Rhinovirus - immunology
Virus Shedding
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intercellular adhesion molecule-1 (ICAM-1) is the cell surface receptor for the major class of human rhinoviruses, and tICAM453, a truncated, soluble form of ICAM-1, has been shown previously to be a potent in vitro inhibitor of rhinovirus. In this report, we have investigated the in vivo efficacy of tICAM453 for the prophylaxis of rhinovirus serotype 16 infection in the chimpanzee. Because chimpanzees do not show clinical symptoms of infection after rhinovirus challenge, infection was followed by measuring antirhinovirus serum antibody responses and detection of virus shedding. By both of these measures, intranasal application of tICAM453 was efficacious in preventing rhinovirus infection in chimpanzees subsequently challenged with infectious doses of virus. These results suggest that the use of soluble rhinovirus receptor to inhibit virus binding to host cells should be feasible in humans.
ISSN:1073-449X
1535-4970
DOI:10.1164/ajrccm.155.4.9105055